Disposable scope takes on gold standard in pleural diagnosis

NCT ID NCT07726784

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This pilot trial tests whether a single-use flexible bronchoscope can safely and effectively replace the semi-rigid pleuroscope for diagnosing pleural effusion—a buildup of fluid around the lungs. Hospitalized patients needing a tissue sample will be randomly assigned to one of the two devices. The study focuses on feasibility, including how often the procedure is completed successfully, and compares procedure time and safety.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
single-use flexible bronchoscope
What this could lead to
If the disposable flexible scope proves as safe and effective as the standard tool, it could offer a cheaper, more accessible option for diagnosing pleural effusion.
What could go wrong
This is a small pilot study with only 36 participants, so results may not apply broadly. The flexible scope may be harder to use or provide poorer views than the standard device.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT PLEURAL EFFUSIONS (MPE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myeloproliferative disorder, chronic, with eosinophilia Pleural Effusion Pleural Effusion, Malignant

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hospital Canselor Tuanku Muhriz, National University of Malaysia,

    Cheras, Kuala Lumput, 56000, Malaysia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.